ReachMD

Episodes 1-15 of 448

• • 

    

    Alberto Sobrero, MD

    Peer

  1

  

  RestartResume

  Recent Advances in the Use of Anti-EGFR for Metastatic Colorectal Cancer

• • 

    

    Claus-Henning Kohne, MD

    Peer

  0

  

  RestartResume

  A Closer Look at the RAS Wild-Type CRC Treatment Landscape

• • 

    

    Volker Heinemann

    Peer

  0

  

  RestartResume

  Managing mCRC Based on Prognostic Factors

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Kristin Higgins, MD

    Peer

  1

  

  RestartResume

  Best Practices for Curative-Intent Concurrent Chemoradiation Therapy in Unres...

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Alexander Whitley, MD

    Peer

  • 

    

    Alejandro Calvo, MD

    Peer

  • 

    

    Kim Rohan, MS APN, AOCN

    Peer

  2

  

  RestartResume

  Multidisciplinary Perspectives on Managing Patients with Unresectable Stage I...

• • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Tarek M. Mekhail, MD, MSC, FRCSI, FRCSEd

    Peer

  0

  

  RestartResume

  Insights from the Latest Clinical Trials in Lung Cancer

• • 

    

    George R. Simon, MD

    Peer

  • 

    

    Yasir Y. Elamin, MD

    Peer

  • 

    

    Howard (Jack) West, MD

    Peer

  1

  

  RestartResume

  Enhancing Your Lung Cancer Practice: Applying Shared Decision Making in the R...

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Robert Foote, MD

    Peer

  • 

    

    Anita Mahajan, MD

    Peer

  0

  

  RestartResume

  Perspectives on Proton Beam Therapy: Benefits, Challenges, & Results

• • 

    

    George R. Simon, MD

    Peer

  • 

    

    Yasir Y. Elamin, MD

    Peer

  • 

    

    Howard (Jack) West, MD

    Peer

  1

  

  RestartResume

  Shared Decision Making in Today’s Clinical Reality

• • 

    

    C. Kent Osborne, MD

    Peer

  0

  

  RestartResume

  A Look at What’s Ahead in Breast Cancer Care

• • 

    

    William Mencia, MD, FACEHP, CHCP

    Peer

  • 

    

    Roy F. Chemaly, MD, MPH, FIDSA, FACP

    Peer

  4

  

  RestartResume

  Combating CMV in HCT Recipients: A New Era of Therapy

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    William Levin, MD

    Peer

  1

  

  RestartResume

  The Role of Integrative Therapy in Cancer Care

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Lauren Nye, MD

    Peer

  2

  

  RestartResume

  New Perspectives on the Impact of Omega 3 Supplements on Breast Cancer Risk

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Nadine Tung, MD

    Peer

  1

  

  RestartResume

  What to Look for When Testing for Hereditary Breast Cancer

• • 

    

    Michael D. Tarantino, MD

    Peer

  1

  

  RestartResume

  Inhibitor Insights: Stanley’s Journey, a Case Study in Acquired Hemophilia A

• 1
• 2
• 3
• …
• 29
• 30
• Next